|
1
|
INCA. 2013, Instituto Nacional do Câncer.
Ministério da Saúde. http://www.inca.gov.br/estimativa/2012/.
Accessed January 10, 2013
|
|
2
|
Kim MS, Lee J and Sidransky D: DNA
methylation markers in colorectal cancer. Cancer Metastasis Rev.
29:181–206. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pellegrini ML, Argibay P and Gómez DE:
Genetics and epigenetics of colorectal cancer. Acta Gastroenterol
Latinoam. 41:247–261. 2011.(In Spanish).
|
|
4
|
Toribara NW and Sleisenger MH: Screening
for colorectal cancer. N Eng J Med. 332:861–867. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Winawer SJ: Colorectal cancer screening.
Best Pract Res Clin Gastroenterol. 21:1031–1048. 2007. View Article : Google Scholar
|
|
6
|
Pignone MP and Lewis CL: Using quality
improvement techniques to increase colon cancer screening. Am J
Med. 122:419–420. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Atkin W: Options for screening for
colorectal cancer. Scand J Gastroenterol Suppl. 237:13–16. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Imperiale TF, Ransohoff DF, Itzkowitz SH,
et al: Fecal DNA versus fecal occult blood for colorectal-cancer
screening in an average-risk population. N Engl J Med.
351:2704–2714. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Grützmann R, Molnar B, Pilarsky C, et al:
Sensitive detection of colorectal cancer in peripheral blood by
septin 9 DNA methylation assay. PLoS One. 3:e37592008.PubMed/NCBI
|
|
10
|
Grady WM and Carethers JM: Genomic and
epigenetic instability in colorectal cancer pathogenesis.
Gastroenterology. 135:1079–1099. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vogelstein B, Fearon ER, Hamilton SR, et
al: Genetic alterations during colorectal-tumor development. N Eng
J Med. 319:525–532. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carmona FJ and Esteller M: Epigenomics of
human colon cancer. Mutat Res. 693:53–60. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rawson JB and Bapat B: Epigenetic
biomarkers in colorectal cancer diagnostics. Expert Rev Mol Diagn.
12:499–509. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Conover WI: Practcal Nonparametric
Statistics. 1st edition. John Wiley & Sons, Inc; New York, NY,
USA: 1971
|
|
15
|
Daniel WW and Cross CL: Biostatistics: a
foundation for analysis in the health sciences. 6th edition. John
Wiley; Georgia, USA: 1995
|
|
16
|
Migheli F and Migliore L: Epigenetics of
colorectal cancer. Clin Genet. 81:312–318. 2012. View Article : Google Scholar
|
|
17
|
Lange CP, Campan M, Hinoue T, et al:
Genome-scale discovery of DNA-methylation biomarkers for
blood-based detection of colorectal cancer. PLoS One. 7:e502662012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Karpf AR and Jones DA: Reactivating the
expression of methylation silenced genes in human cancer. Oncogene.
21:5496–5503. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schuebel KE, Chen W, Cope L, et al:
Comparing the DNA hypermethylome with gene mutations in human
colorectal cancer. PLoS Genet. 3:1709–1723. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lofton-Day C, Model F, Devos T, et al: DNA
methylation biomarkers for blood-based colorectal cancer screening.
Clin Chem. 54:414–423. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goel A and Boland CR: Epigenetics of
colorectal cancer. Gastroenterology. 143:1442–1460. 2012.
View Article : Google Scholar
|
|
22
|
Ausch C, Kim YH, Tsuchiya KD, et al:
Comparative analysis of PCR-based biomarker assay methods for
colorectal polyp detection from fecal DNA. Clin Chem. 55:1559–63.
2009. View Article : Google Scholar : PubMed/NCBI
|
